Jeffrey Rosenfeld

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial

Merit Cudkowicz, Sarah Titus, Marianne Kearney et al. · The Lancet Neurology · 2014 · 239 citations

Medicine, Neurology, Pharmacology +10

Whole-Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis

Travis Dunckley, Matthew J. Huentelman, David W. Craig et al. · New England Journal of Medicine · 2007 · 237 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis

Merit Cudkowicz, Jeremy M. Shefner, David Schoenfeld et al. · Neurology · 2003 · 204 citations

Medicine, Neurology, Pharmacotherapy +17

A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients

Carlayne E. Jackson, Jeffrey Rosenfeld, Dan H. Moore et al. · Journal of the Neurological Sciences · 2001 · 154 citations

Medicine, Neurology, Pulmonary Function Testing +12